×

img Acces sibility Controls

Research Projects Banner

Research Projects

Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease

Funding Organization
Funding Organization
Gilead Sciences, Inc., USA
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Gastroenterology
Start Year
2017
End Year
2021
Sanction Amount
₹ 10.00 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop